Literature DB >> 17923359

BNP in overweight and obese patients with heart failure: an analysis based on the BNP-LV diastolic wall stress relationship.

Yoshitaka Iwanaga1, Yasuki Kihara, Shinichiro Niizuma, Teruo Noguchi, Hiroshi Nonogi, Toru Kita, Yoichi Goto.   

Abstract

BACKGROUND: Suppressed plasma B-type natriuretic peptide (BNP) levels have been reported in obese individuals with heart failure (HF). However, the precise mechanism and significance of this relationship in the clinical setting of HF are unknown. Recently, we reported a close association between BNP levels and left ventricular end-diastolic wall stress (EDWS) as the underlying mechanism of BNP secretion; therefore, we investigated the relationship between BMI and plasma BNP levels in HF while adjusting for EDWS. METHODS AND
RESULTS: In 245 consecutive patients who presented with HF, we measured plasma BNP levels and performed echocardiography and cardiac catheterization. Meridional EDWS was calculated from echocardiographic and hemodynamic parameters. The body mass index (BMI) for the total population was 22.9 +/- 0.2 kg/m2; 21% were lean (BMI < 20) and 27% overweight and obese (BMI > or = 25). The correlation between plasma BNP and EDWS [r = 0.771 (P <.001)] was more robust than any other echocardiographic or hemodynamic parameter as well as any patient's characteristics. By a univariate analysis, BMI was inversely correlated with both BNP levels and EDWS (P <.001 in both). However, a multivariable regression analysis that took into account EDWS demonstrated a significant inverse association between BMI and BNP (P <.001).
CONCLUSION: The present study demonstrates that BMI determines the BNP level in a manner that is independent of the hemodynamic load in patients with HF. Overweight and obesity should be considered to be associated with the interindividual variability of plasma BNP levels in the diagnosis and management of HF patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923359     DOI: 10.1016/j.cardfail.2007.05.002

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  6 in total

Review 1.  The paradox of low BNP levels in obesity.

Authors:  Aldo Clerico; Alberto Giannoni; Simona Vittorini; Michele Emdin
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

2.  Brain natriuretic hormone predicts stress-induced alterations in diastolic function.

Authors:  Pratik Choksy; Harry C Davis; James Januzzi; Julian Thayer; Gregory Harshfield; Vincent J B Robinson; Gaston K Kapuku
Journal:  Am J Med Sci       Date:  2014-11       Impact factor: 2.378

3.  Impact of obesity on plasma B-type natriuretic peptide levels in Japanese community-based subjects.

Authors:  Megumi Koizumi; Hiroyuki Watanabe; Yoshihiro Kaneko; Kenji Iino; Masaru Ishida; Toshimitsu Kosaka; Yutaka Motohashi; Hiroshi Ito
Journal:  Heart Vessels       Date:  2011-04-28       Impact factor: 2.037

4.  Left Ventricular Diastolic Myocardial Stiffness and End-Diastolic Myofibre Stress in Human Heart Failure Using Personalised Biomechanical Analysis.

Authors:  Zhinuo J Wang; Vicky Y Wang; Chris P Bradley; Martyn P Nash; Alistair A Young; J Jane Cao
Journal:  J Cardiovasc Transl Res       Date:  2018-07-11       Impact factor: 4.132

5.  Positive influence of being overweight/obese on long term survival in patients hospitalised due to acute heart failure.

Authors:  Simona Littnerova; Jiri Parenica; Jindrich Spinar; Jirí Vitovec; Ales Linhart; Petr Widimsky; Jiri Jarkovsky; Roman Miklik; Lenka Spinarova; Kamil Zeman; Jan Belohlavek; Filip Malek; Marian Felsoci; Jiri Kettner; Petr Ostadal; Cestmir Cihalik; Jiri Spac; Hikmet Al-Hiti; Marian Fedorco; Richard Fojt; Andreas Kruger; Josef Malek; Tereza Mikusová; Zdenek Monhart; Stanislava Bohacova; Lidka Pohludkova; Filip Rohac; Jan Vaclavik; Dagmar Vondrakova; Klaudia Vyskocilova; Miroslav Bambuch; Ladislav Dusek
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

6.  Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fraction.

Authors:  Samuel Tate; Andrea Griem; Blythe Durbin-Johnson; Clifton Watt; Saul Schaefer
Journal:  J Biomed Res       Date:  2014-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.